Gilead Sciences licenses three preclinical antiviral programs from Novartis
US biopharma company Gilead Sciences has licensed three preclinical antiviral programs, including investigational candidates having the potential to treat human
The post Gilead Sciences licenses three preclinical antiviral programs from Novartis appeared first on PharmaNewsDaily.com.
AbbVie to acquire Botox developer Allergan for $63bn
AbbVie acquisition of Allergan : US biopharma company AbbVie is all set to acquire Botox developer Allergan, an Irish pharma
The post AbbVie to acquire Botox developer Allergan for $63bn appeared first on PharmaNewsDaily.com.
Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer
Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of…
Celgene bags Otezla FDA approval for oral ulcers in Behcet’s Disease
Otezla FDA approval : US biotech company Celgene has bagged approval from the US Food and Drug Administration…
Rising to launch generic version of Pregabalin Capsules in US
Rising Pharmaceuticals has launched a generic version of Lyrica, (pregabalin) Capsules in the US, in all eight commercially…
PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as…
Merck bags Recarbrio FDA approval for urinary tract and intra-abdominal infections
Recarbrio FDA approval : Merck & Co. has secured approval from the US Food and Drug Administration (FDA)…
Convelo, Genentech to collaborate on remyelination drugs for MS
US biotech company Convelo Therapeutics has signed an exclusive worldwide collaboration with Roche subsidiary Genentech to fast track…
Know how to deal with skin rashes in babies
Skin care is an essential step for babies overall health as they have delicate skin and is prone…
Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics
Boehringer Ingelheim acquisition of AMAL Therapeutics : German pharma company Boehringer Ingelheim has acquired Swiss biotech company AMAL…